Logo image of AIDX.CA

HEALWELL AI INC (AIDX.CA) Stock Fundamental Analysis

Canada - TSX:AIDX - CA42249X1006 - Common Stock

1.52 CAD
+0.11 (+7.8%)
Last: 10/14/2025, 7:00:00 PM
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to AIDX. AIDX was compared to 15 industry peers in the Health Care Providers & Services industry. Both the profitability and financial health of AIDX have multiple concerns. While showing a medium growth rate, AIDX is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year AIDX has reported negative net income.
AIDX had a negative operating cash flow in the past year.
AIDX had negative earnings in each of the past 5 years.
AIDX had negative operating cash flow in 4 of the past 5 years.
AIDX.CA Yearly Net Income VS EBIT VS OCF VS FCFAIDX.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 -10M -20M -30M

1.2 Ratios

AIDX has a Return On Assets of -33.40%. This is amonst the worse of the industry: AIDX underperforms 80.00% of its industry peers.
Looking at the Return On Equity, with a value of -65.63%, AIDX is doing worse than 66.67% of the companies in the same industry.
Industry RankSector Rank
ROA -33.4%
ROE -65.63%
ROIC N/A
ROA(3y)-41.98%
ROA(5y)-31.25%
ROE(3y)-156.63%
ROE(5y)-292.43%
ROIC(3y)N/A
ROIC(5y)N/A
AIDX.CA Yearly ROA, ROE, ROICAIDX.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 -200 -400 -600 -800

1.3 Margins

With a decent Gross Margin value of 47.18%, AIDX is doing good in the industry, outperforming 73.33% of the companies in the same industry.
AIDX's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for AIDX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 47.18%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y12.28%
GM growth 5Y6.15%
AIDX.CA Yearly Profit, Operating, Gross MarginsAIDX.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300 -400

More info and screens

3

2. Health

2.1 Basic Checks

AIDX does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for AIDX has been increased compared to 1 year ago.
Compared to 5 years ago, AIDX has more shares outstanding
AIDX has a better debt/assets ratio than last year.
AIDX.CA Yearly Shares OutstandingAIDX.CA Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
AIDX.CA Yearly Total Debt VS Total AssetsAIDX.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

An Altman-Z score of 2.28 indicates that AIDX is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.28, AIDX is in the better half of the industry, outperforming 73.33% of the companies in the same industry.
AIDX has a Debt/Equity ratio of 0.40. This is a healthy value indicating a solid balance between debt and equity.
AIDX has a Debt to Equity ratio of 0.40. This is amongst the best in the industry. AIDX outperforms 86.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF N/A
Altman-Z 2.28
ROIC/WACCN/A
WACC7.94%
AIDX.CA Yearly LT Debt VS Equity VS FCFAIDX.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M

2.3 Liquidity

A Current Ratio of 0.79 indicates that AIDX may have some problems paying its short term obligations.
AIDX has a Current ratio of 0.79. This is comparable to the rest of the industry: AIDX outperforms 46.67% of its industry peers.
AIDX has a Quick Ratio of 0.79. This is a bad value and indicates that AIDX is not financially healthy enough and could expect problems in meeting its short term obligations.
AIDX has a Quick ratio (0.79) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 0.79
Quick Ratio 0.79
AIDX.CA Yearly Current Assets VS Current LiabilitesAIDX.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

More info and screens

5

3. Growth

3.1 Past

AIDX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 54.46%, which is quite impressive.
Looking at the last year, AIDX shows a very strong growth in Revenue. The Revenue has grown by 238.69%.
AIDX shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -3.38% yearly.
EPS 1Y (TTM)54.46%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-200%
Revenue 1Y (TTM)238.69%
Revenue growth 3Y-6.59%
Revenue growth 5Y-3.38%
Sales Q2Q%644.62%

3.2 Future

The Earnings Per Share is expected to grow by 22.20% on average over the next years. This is a very strong growth
AIDX is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 56.59% yearly.
EPS Next Y56.97%
EPS Next 2Y32.85%
EPS Next 3Y22.2%
EPS Next 5YN/A
Revenue Next Year243.72%
Revenue Next 2Y116.62%
Revenue Next 3Y73.05%
Revenue Next 5Y56.59%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
AIDX.CA Yearly Revenue VS EstimatesAIDX.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M
AIDX.CA Yearly EPS VS EstimatesAIDX.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 0 -0.1 -0.2 -0.3 -0.4

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for AIDX. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for AIDX. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AIDX.CA Price Earnings VS Forward Price EarningsAIDX.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AIDX.CA Per share dataAIDX.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2

4.3 Compensation for Growth

A more expensive valuation may be justified as AIDX's earnings are expected to grow with 22.20% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y32.85%
EPS Next 3Y22.2%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for AIDX!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

HEALWELL AI INC

TSX:AIDX (10/14/2025, 7:00:00 PM)

1.52

+0.11 (+7.8%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)08-13 2025-08-13/dmh
Earnings (Next)11-10 2025-11-10
Inst Owners0.83%
Inst Owner ChangeN/A
Ins Owners14.26%
Ins Owner ChangeN/A
Market Cap422.88M
Analysts83.53
Price Target3.52 (131.58%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-37.54%
Min EPS beat(2)-70.5%
Max EPS beat(2)-4.58%
EPS beat(4)0
Avg EPS beat(4)-143.35%
Min EPS beat(4)-467.59%
Max EPS beat(4)-4.58%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-1.07%
Min Revenue beat(2)-1.58%
Max Revenue beat(2)-0.56%
Revenue beat(4)1
Avg Revenue beat(4)-0.46%
Min Revenue beat(4)-3%
Max Revenue beat(4)3.32%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-75%
EPS NY rev (1m)-0.53%
EPS NY rev (3m)-50%
Revenue NQ rev (1m)-0.53%
Revenue NQ rev (3m)-5.59%
Revenue NY rev (1m)-0.27%
Revenue NY rev (3m)-3.29%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 5.06
P/FCF N/A
P/OCF N/A
P/B 6.62
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.38
EYN/A
EPS(NY)-0.08
Fwd EYN/A
FCF(TTM)-0.07
FCFYN/A
OCF(TTM)-0.07
OCFYN/A
SpS0.3
BVpS0.23
TBVpS-0.11
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -33.4%
ROE -65.63%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 47.18%
FCFM N/A
ROA(3y)-41.98%
ROA(5y)-31.25%
ROE(3y)-156.63%
ROE(5y)-292.43%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y12.28%
GM growth 5Y6.15%
F-Score5
Asset Turnover0.67
Health
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 14.85%
Cap/Sales 2.15%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.79
Quick Ratio 0.79
Altman-Z 2.28
F-Score5
WACC7.94%
ROIC/WACCN/A
Cap/Depr(3y)14.05%
Cap/Depr(5y)20.98%
Cap/Sales(3y)2.16%
Cap/Sales(5y)2.4%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)54.46%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-200%
EPS Next Y56.97%
EPS Next 2Y32.85%
EPS Next 3Y22.2%
EPS Next 5YN/A
Revenue 1Y (TTM)238.69%
Revenue growth 3Y-6.59%
Revenue growth 5Y-3.38%
Sales Q2Q%644.62%
Revenue Next Year243.72%
Revenue Next 2Y116.62%
Revenue Next 3Y73.05%
Revenue Next 5Y56.59%
EBIT growth 1Y-5.78%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year105.86%
EBIT Next 3Y39.33%
EBIT Next 5Y34.46%
FCF growth 1Y-189.42%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-178.81%
OCF growth 3YN/A
OCF growth 5YN/A